Comparison of functional parameters of constitutive and hypoxia-induced expression plasmids during acute ischemia of lower extremities.

Suppr

超能文献

作者信息

Nikulina N A, Kalashnikova M V, Belyavskii A V, Golantsova N E

机构信息

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, ul. Vavilova 32, Moscow, 119991 Russia.

出版信息

Dokl Biochem Biophys. 2006 Jan-Feb;406:32-5. doi: 10.1134/s1607672906010091.

DOI:10.1134/s1607672906010091

PMID:16584003

Abstract

摘要

相似文献

Comparison of functional parameters of constitutive and hypoxia-induced expression plasmids during acute ischemia of lower extremities.

Dokl Biochem Biophys. 2006 Jan-Feb;406:32-5. doi: 10.1134/s1607672906010091.

Insights into gene therapy for critical limb ischemia: the devil is in the details.

Vascul Pharmacol. 2012 Aug 19;57(1):10-4. doi: 10.1016/j.vph.2012.05.001. Epub 2012 May 8.

Hypoxia-inducible factor 1 in lower limb ischemia.

Vascular. 2006 Nov-Dec;14(6):321-7. doi: 10.2310/6670.2006.00056.

[Genetic engineering potential and perspectives in the management of critical ischemia].

Angiol Sosud Khir. 2003;9(3):14-8.

[Gene and cell therapy in lower limb critical ischemia].

Rev Med Interne. 2007 Jun;28 Suppl 1:S2-4. doi: 10.1016/j.revmed.2007.03.017. Epub 2007 Apr 9.

Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia.

Eur J Vasc Endovasc Surg. 2015 Oct;50(4):494-501. doi: 10.1016/j.ejvs.2015.05.007. Epub 2015 Jun 27.

[Sendai virus based vectors].

Uirusu. 2003 Dec;53(2):171-5. doi: 10.2222/jsv.53.171.

Phase Ib Safety, Two-Dose Study of MultiGeneAngio in Patients with Chronic Critical Limb Ischemia.

Mol Ther. 2017 Mar 1;25(3):816-825. doi: 10.1016/j.ymthe.2016.12.019. Epub 2017 Jan 28.

[Worldwide experience and recent trends in gene therapy of ischaemic diseases].

Angiol Sosud Khir. 2011;17(2):145-54.

Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia.

Circ Res. 2007 Dec 7;101(12):1310-8. doi: 10.1161/CIRCRESAHA.107.153346. Epub 2007 Oct 11.

本文引用的文献

Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end?

Nat Clin Pract Cardiovasc Med. 2005 Mar;2(3):138-44. doi: 10.1038/ncpcardio0136.

Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.

Trends Cardiovasc Med. 2004 Nov;14(8):295-300. doi: 10.1016/j.tcm.2004.09.001.

Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts.

Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16280-5. doi: 10.1073/pnas.0407449101. Epub 2004 Nov 8.

Hydroxylation of HIF-1: oxygen sensing at the molecular level.

Physiology (Bethesda). 2004 Aug;19:176-82. doi: 10.1152/physiol.00001.2004.

Genetic and cellular therapies for cerebral infarction.

Neurosurgery. 2004 Aug;55(2):283-6; discussion 296-7. doi: 10.1227/01.neu.0000129681.85731.00.

Regulation of transcription and translation by hypoxia.

Cancer Biol Ther. 2004 Jun;3(6):492-7. doi: 10.4161/cbt.3.6.1010. Epub 2004 Jun 8.

Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis.

Circulation. 2004 Jun 15;109(23):2826-31. doi: 10.1161/01.CIR.0000132468.82942.F5.

Therapeutic angiogenesis using hepatocyte growth factor (HGF).

Curr Gene Ther. 2004 Jun;4(2):199-206. doi: 10.2174/1566523043346453.

Gene transfer as a tool to induce therapeutic vascular growth.

Nat Med. 2003 Jun;9(6):694-701. doi: 10.1038/nm0603-694.

Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model.

Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9480-5. doi: 10.1073/pnas.132275299. Epub 2002 Jun 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验